Accelerating Conjugation Process Development for Next-Generation ADCs: Key Considerations and Platform Strategies
In this webinar, Dr. Peng reviews the current ADC landscape and share key considerations and platform strategies to accelerate conjugation process development for next-gen ADCs.
ADC Payload-Linker CMC Process Development Strategy
Hear Dr. Zheng Wei share a comprehensive payload-linker CMC development strategy that covers regulatory guidance, RSM selection, and stage-appropriate quality control to navigate the evolving complexities of ADC design from IND to NDA.
Integrating Regulatory Guidance and Sustainable Skin Procurement for Consistent Execution of In Vitro Permeation Testing
Join LifeNet Health LifeSciences for our first Assay Services webinar, focusing on Dermal Absorption. This session explores in vitro permeation testing, a crucial method for assessing a compound’s potential to penetrate the skin and reach systemic circulation.
Breaking the Bottleneck: Harnessing Proteomics Services to Overcome Challenges in Clinical Research
This webinar will demonstrate how integrating high-plex proteomics services can help overcome barriers, accelerating decision-making throughout drug development.
Towards Eliminating Small Molecule Toxicity: Axiom’s AI Models for Clinical Safety Assessment
Join Axiom’s webinar to explore how AI/ML enhances clinical toxicity assessments, delivering accurate, cost-effective DILI risk predictions at human exposure levels.
Supporting the Development of Biologics Through the IND‑Enabling Studies and Clinical Phases
In this webinar, Dr. Linda Randall shares how Pharmaron’s global teams are supporting the development of biological drugs from discovery to commercial supply.
From Bench to Clinic: Decoding the IND Roadmap for Innovative Cell and Gene Therapies
Join Dr. Grace Lee and Dr. Frederik Deroose as they discuss important considerations and challenges during the Investigational New Drug (IND) application process, with a focus on cell and gene therapy.
Evaluation of Novel Therapies Using Spontaneous Seizure Models
Cameron Metcalf and Katrina Irey answer questions from a recent webinar on technical requirements and benefits of spontaneous seizure models and epilepsy therapy development.
Evaluation of Novel Therapies Using Spontaneous Seizure Models
In this webinar, Dr. Cameron Metcalf covers the technical requirements and benefits of spontaneous seizure models, addressing the challenges and optimization of 24/7 video-EEG data collection for epilepsy therapy development.
The Sweet Truth: Unwrapping the Science of Semaglutide
Semaglutide, also known as Ozempic and Wegovy, has become increasingly popular -- but why? Here we discuss the mechanism behind these drugs, how they've become so well known, and what current research says about their long-term effects.
#ExpertAnswers: Audrey Dubourg and Gareth Guenigault on the Organ-On-A-Chip Approach
Audrey Dubourg and Gareth Guenigault from CN Bio discuss the value that an organ-on-a-chip approach can bring to drug discovery and development workflows, and how the regulatory landscape is shifting to encourage their widespread adoption.
It’s Life, but Not As We Know It: How Predictive Human Organ Models Are Transforming and Reshaping the Efficiency of Drug Discovery
Dr. Audrey Dubourg and Dr. Gareth Guenigault explore the value that an organ-on-a-chip approach can bring to drug discovery and development workflows, and how the regulatory landscape is shifting to encourage their widespread adoption.
